Salvatore Luca Burgio Selected Research

Prostatic Neoplasms (Prostate Cancer)

3/2024	Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.
12/2020	Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.
12/2019	Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA Analysis.
11/2019	Plasma Androgen Receptor in Prostate Cancer.
1/2019	Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide.
1/2019	Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors.
10/2018	Plasma androgen receptor and serum chromogranin A in advanced prostate cancer.
1/2018	AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate Cancer.
1/2018	Association among metabolic syndrome, inflammation, and survival in prostate cancer.
7/2016	CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore Luca Burgio Research Topics

Disease

16	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 06/2014
5	Neoplasms (Cancer) 01/2020 - 05/2014
4	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 05/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 09/2016
2	Ovarian Epithelial Carcinoma 01/2021 - 12/2018
2	Neoplasm Metastasis (Metastasis) 12/2020 - 09/2013
1	Disease Resistance 03/2024
1	Ascites 01/2023
1	Carcinoma (Carcinomatosis) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Urologic Neoplasms (Urological Cancer) 01/2019
1	Disease Progression 01/2019
1	Adenocarcinoma 10/2018
1	Stomatitis 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Mucositis 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2015

Drug/Important Bio-Agent (IBA)

9	enzalutamideIBA 12/2020 - 12/2014
6	abirateroneIBA 01/2019 - 06/2014
5	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 01/2018
3	PlatinumIBA 01/2023 - 12/2018
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2019
3	Chromogranin AIBA 10/2018 - 06/2014
3	Docetaxel (Taxotere)FDA Link 07/2015 - 06/2014
2	Hormones (Hormone)IBA 12/2020 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2020 - 06/2015
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	NivolumabIBA 01/2020 - 09/2016
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	Alkylating AgentsIBA 01/2021
1	AndrogensIBA 12/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Cell-Free Nucleic AcidsIBA 11/2019
1	AnthracyclinesIBA 05/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	CytokinesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Androgen Antagonists (Antiandrogens)IBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018
1	Leucovorin (Folinic Acid)FDA Link 12/2018
1	Fluorouracil (Carac)FDA LinkGeneric 12/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	Everolimus FDA Link 01/2017
1	nasIBA 07/2015
1	cabazitaxel FDA Link 07/2015
1	Abiraterone AcetateIBA 07/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2015
1	Hemoglobins (Hemoglobin)IBA 06/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2015
1	pentetreotide (OctreoScan)FDA Link 02/2015
1	Angiogenesis InhibitorsIBA 05/2014

Therapy/Procedure

15	Castration 03/2024 - 06/2014
10	Therapeutics 03/2024 - 09/2013
7	Drug Therapy (Chemotherapy) 01/2023 - 09/2013
2	Immunotherapy 01/2020 - 01/2019
1	Adjuvant Chemotherapy 01/2023
1	Radiotherapy 09/2013